Seminar: CANSSI Ontario STAGE Monthly Seminar Series


Seminar: CANSSI Ontario STAGE Monthly Seminar Series

[img]

December 06, 2019 - 07:44 - 12:00
Team: Events, Training & News
Posted on November 28, 2019
 Add to your calendar as an .ics file

CHIMb.ca
[img]

Seminar: CANSSI Ontario STAGE Monthly Seminar Series

Team: Events, Training & News

December 06, 2019 - 07:44 - 12:00

Description


CANSSI Ontario STAGE: International Speaker Seminar Series

The George & Fay Yee Centre for Healthcare Innovation is hosting the CANSSI Ontario STAGE (Strategic Training for Advanced Genetic Epidemiology) International Speaker Monthly Seminar Series. This is a formal and comprehensive training program in Genetic Epidemiology and Statistical Genetics. CANSSI Ontario STAGE aims to expose trainees to high-calibre international research and foster a cohesive research community of genetic epidemiologists, statistical geneticists and bioinformatician in Canada through this series, and in the context of genetic epidemiology, statistical genetics and bioinformatics research. Please submit any questions via email to pingzhao.hu@umanitoba.ca

December 6, 2019
11:00 am - 12:00pm
Room 341, Basic Medical Sciences Building, University of Manitoba, 730 William Ave.

This session will be offered via webcast (the live session will take place in Toronto).

Abstract

The Alkek Center for Metagenomics and Microbiome Research (CMMR) at Baylor College of Medicine is pursuing numerous research and development efforts in the study of how the microbiome impacts human disease, including autoimmune disease, neurodevelopmental disorders, cancer, and type 1 diabetes. Among these efforts are the benchmarking and validation of protocols and strategies to engage large, complex cohorts and unique sample sources for metagenomic analyses. In addition, we have made a significant investment in preclinical model  systems facilitate host-microbe studies and connect association to causality, as this is a critical hurdle for any microbiome research program. Among these models are a large germ free rodent facility and physiologically active human culture systems that mimic host susceptibility and response to determine microbe-host interactions of mucosal diseases. By implementing ‘omicsbased approaches with these translational models, we are beginning to reveal host responses to microbial colonization and infection which can inform precision medicine-based targets for the detection and treatment of disease.

Speaker:

Dr. Joseph Petrosino

Cullen Foundation Endowed Chair
Chairman, Department of Molecular Virology and Microbiology
Director, Alkek Center for Metagenomics and Microbiome Research
Human Genome Sequencing Center
Dan L. Duncan Cancer Center Department of Opthamology
Baylor College of Medicine

Dr. Petrosino was a principal investigator for the NIH Common Fund Human Microbiome Project and, in 2011, established the Alkek Center for Metagenomics and Microbiome Research (CMMR), with its mission to develop and implement advanced technologies to understand how the human microbiome impacts health and disease and translate this knowledge for better therapeutics and diagnostics.

Over the past eight years, the CMMR has established over 400 microbiome-related projects with over 200 collaborators worldwide. Among the most promising projects is a comprehensive microbiome analysis of 28,000+ type 1 diabetes (T1D) samples from the NIH/NIDDK TEDDY (The Environmental Determinants of Diabetes in the Young) prospective cohort which has the goal of identifying microbial taxonomic and functional associations, and potentially triggers, for T1D. Additionally, the Petrosino laboratory is employing a variety of biological and engineering approaches to isolate and fractionate and culture live microbial cells for study of their role in human health and for use in personalized medicine applications where microbiome interventions are being considered.

In 2013, Dr. Petrosino founded Diversigen, a BCM Technologies start-up where the robust pipelines built in the CMMR have been commercialized to support biotech and pharmaceutical company needs in the microbiome and metagenomics-related arenas. He has contributed to more than 120 peer-reviewed microbiome studies, and his achievements in the microbiome arena led him to be named an American Society for Microbiology Distinguished lecturer from 2012-2014 

 Add this event to your calendar

 

Documents and Photos